Filing Details
- Accession Number:
- 0001171843-17-004789
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-07 18:00:16
- Reporting Period:
- 2017-08-03
- Filing Date:
- 2017-08-07
- Accepted Time:
- 2017-08-07 18:00:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 3116 | Akorn Inc | AKRX | Pharmaceutical Preparations (2834) | 720717400 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1234725 | Bruce Kutinsky | 1925 West Field Court Suite 300 Lake Forest IL 60045 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-03 | 100,000 | $13.35 | 317,480 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-08-03 | 40,000 | $33.46 | 277,480 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-08-03 | 25,541 | $33.45 | 251,939 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2017-08-03 | 100,000 | $0.00 | 100,000 | $13.35 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-08-03 | No | 4 | M | Direct |
Footnotes
- Proceeds from the sale were used to pay the exercise price for this option exercise.
- Represents the weighted average sale price of the shares sold. The shares were sold at prices ranging from $33.41 to $33.51. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at separate prices within the foregoing range.
- The shares were withheld for the payment of the taxes due upon exercise of the options.
- Equals the closing market price of Akorn common stock on August 3, 2017.
- Following the reported transaction, the amount of shares beneficially owned consists of 55,203 unvested RSUs and 196,736 shares owned outright.
- The stock options vested in four equal installments of 25,000 each on August 3, 2013, August 3, 2014, August 3, 2015 and August 3, 2016.
Billionaire Hedge Funds
